Cancer Treatment Centers of America in Tulsa Reaches New Milestones – Receives National Breast Center Accreditation and Opens Stem Cell Transplant Unit

Cancer Treatment Centers of America in Tulsa Reaches New Milestones – Receives National Breast Center Accreditation and Opens Stem Cell Transplant Unit

<0> Cancer Treatment Centers of AmericaKendra Thompson, 918-286-5668orMary Waller, 918-587-1909 </0>

Cancer Treatment Centers of America’s (CTCA) Oklahoma hospital realized two major milestones this spring with recognition by the National Accreditation Program for Breast Centers (NAPBC) and the opening of the facility’s new Stem Cell Transplant Unit.

CTCA’s Tulsa hospital serves cancer patients across all corners of Oklahoma, as well as a multi-state region, and is a cancer program within the American College of Surgeons. The center received the prestigious accreditation for meeting rigorous standards set forth by the NAPBC after undergoing an external evaluation of its performance and compliance standards. “This accreditation illustrates that we are doing what the NAPBC and their experts around the country believe epitomizes excellence in the delivery of coordinated, multidisciplinary breast cancer care,” said Dr. John Frame, CTCA breast surgeon.

The three-year NAPBC accreditation is a reflection of the CTCA’s commitment to patient-centered care, clinical excellence and outstanding follow-up services. NAPBC evaluators studied 17 different disciplines within the Tulsa breast program, including surgical protocols, nursing, quality improvement, plastic surgery and medical oncology.

A second major clinical announcement raising the CTCA profile this spring is the opening of a state-of-the-art Stem Cell Transplant Unit for the treatment of hematology malignancies including, but not limited to, chronic and acute leukemia, Hodgkin’s and Non-Hodgkin’s lymphoma and multiple myelomas.

“We are now able to provide unparalleled in-patient, out-patient services under one roof for those across the state and region for blood cancer patients and stem cell donors,” said Dr. Joseph P. Lynch, MD, MS, medical director of the new unit and cell therapy program. Lynch’s clinical experiences include fellowships in oncology and bone marrow transplantation programs from Pennsylvania, Kentucky and Seattle prior to coming to Oklahoma to lead this CTCA program expansion.

Known for delivering the Mother Standard of care and Patient Empowered Care, CTCA’s national network of five comprehensive medical centers provide patients with information about cancer and their treatment options, so they can control their treatment decisions. To learn more about CTCA Southwestern, visit .